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Abstract
Xylazine (XYL) and acepromazine (ACP) are known to decrease the hematocrit (HT) of horses when administered 
alone. However in routine anesthesia these drugs are administered by associations which ultimate effect in the HT 
is unknown but may cause false impressions about the hydration status, blood loss and red blood cell indices. The 
objective of this study was to characterize the values of HT in horses anesthetized with XYL, ACP, ketamine, midazolam, 
guaiphenesin, isoflurane and ephedrine. Twenty healthy horses were premedicated with either XYL 0.8 mg/kg (XYL 
group, n=10) or XYL 0.5 mg/kg plus ACP 0.05 mg/kg (XYL+ACP group, n=10). Anesthesia was induced with ketamine, 
midazolam and guaiphenesin and maintained with isoflurane. Ephedrine was infused for cardiovascular support. HT, 
vital parameters and blood gas values were evaluated at baseline, between each drug administration, after standing and 
24 hours after baseline (24hBL). The HT started to decrease 17 and 40 minutes after premedication in XYL group and 
XYL+ACP group, respectively (p<0.05). The maximum decrease of 19% in XYL group and 17% in XYL+ACP group 
was observed after 1 hour of premedication (p<0.05). In both groups HT remained low for longer than 180 minutes and 
returned to baseline at 24hBL. A significant HT decrease should be considered in anesthetized healthy horses receiving 
XYL, ACP, ketamine, midazolam, guaiphenesin, isoflurane and ephedrine.
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Resumo
A administração isolada de xilazina (XIL) e acepromazina (ACP) pode diminuir o hematócrito (HT) de equinos. Na 
rotina anestésica, estes fármacos são administrados em associações, cujo efeito final no HT não é conhecido, mas pode 
causar falsas impressões sobre o grau de hidratação, perda sanguínea e índices hematimétricos. O objetivo deste estudo 
foi caracterizar os valores de HT de equinos anestesiados com XYL, ACP, cetamina, midazolam, EGG, isofluorano e 
efedrina. Vinte equinos hígidos foram pré-tratados com XIL 0,8 mg/kg (grupo XIL, n=10) ou XIL 0,5 mg/kg associada 
à ACP 0,05 mg/kg (grupo XIL+ACP, n=10). A anestesia foi induzida com cetamina, midazolam e EGG e mantida com 
isofluorano. A efedrina foi utilizada para suporte cardiovascular. O HT, parâmetros vitais e hemogasometria foram 
avaliados no momento basal, entre administração de cada fármaco, após retorno à posição quadrupedal e 24 horas 
após momento basal (24hBL). A diminuição do HT iniciou-se 17 e 40 minutos após administração da medicação pré-
anestésica no grupo XIL e grupo XIL+ACP, respectivamente (p<0,05). A queda máxima de 19% no grupo XIL e 17% 
no grupo XIL+ACP foi observada após 1 hora da administração da medicação pré-anestésica (p<0,05). Em ambos os 
grupos, o HT permaneceu baixo por mais de 180 minutos e retornou aos valores basais em 24hBL. Deve-se considerar a 
ocorrência de uma redução significativa do HT em equinos hígidos anestesiados com XYL, ACP, cetamina, midazolam, 
EGG, isofluorano e efedrina.  
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Introduction
Xylazine (XYL) and acepromazine (ACP) are com-
monly administered in horses as preanesthetic medi-
cation, which significantly decreases hematocrit (HT) 
by relaxation of the splenic capsule, vasodilation on 
this organ and subsequent sequestration of red blood 
cells1,2,3,4,5,6. Despite HT decrease is expected after ad-
ministration of XYL and ACP, in routine anesthesia 
they are often administered associated with other 
drugs based on the concept of balanced anesthesia, 
which is not known if may result in a different effect 
on HT. Ketamine and ephedrine are capable to in-
crease HT through a sympathomimetic effect, while 
inhalation anesthetics can produce this effect by in-
creasing cortisol release in the circulation.7 This alpha 
adrenergic activity of these drugs produces splenic 
contraction, injecting red blood cells in the circula-
tion. Also, there may be an increase in vascular resis-
tance and intravascular hydrostatic pressure, shifting 
fluid out of the vasculature to the extravascular space 
with an increase in HT by hemoconcentration4,5,8,9.
Since it is not consistently found on the literature 
which is the ultimate effect of these drugs associations 
on HT levels, the hydration status, blood loss and red 
blood cells indices may not be properly estimated dur-
ing anesthesia when XYL and ACP are used. There-
fore, this study aimed to evaluate possible changes in 
HT of healthy horses promoted by two different an-
esthetic protocols consisting of XYL, ACP, ketamine, 
midazolam, guaiphenesin, isoflurane and ephedrine. 
The hypothesis is that the anesthetic protocol that 
includes ACP produces higher HT decrease than the 
anesthetic protocol that does not include ACP. 
Material and Method
This study was approved by the ethics and animal 
investigation committee at our institution (protocol 
number 985/06). The experiments were performed in 
20 healthy cross-bred horses with (mean ± s.d.) 9 ± 5 
years and weighing 431 ± 87 kg scheduled for arthros-
copy surgery. 
Food was withheld for 12 hours and water was al-
ways available before anesthesia. The left jugular vein 
was percutaneously catheterized using a 14 gauge 
catheter (Nipro Medical Ltda. – Sorocaba-SP, Brazil) 
for administration of drugs and lactated Ringer´s so-
lution (10 ml/kg/h). Horses were randomly assigned 
into 2 groups according to the preanesthetic medica-
tion administered: XYL group (n=10) received xyla-
zine (0.8 mg/kg i.v.; Sedazine – Fort Dodge Animal 
Health – Campinas-SP, Brazil) and XYL+ACP group 
(n=10) received xylazine (0.5 mg/kg i.v.; Sedazine – 
Fort Dodge Animal Health – Campinas/SP, Brazil) 
plus acepromazine (0.05 mg/kg i.v.; Acepran 1% - 
Univet S.A. – São Paulo/SP, Brazil). Ten minutes af-
ter preanesthetic medication, anesthesia was induced 
similarly in all horses with ketamine (2 mg/kg i.v.; 
Dopalen – Vetbrands Animal Health – Jacareí-SP, 
Brazil) plus midazolam (0.1 mg/kg i.v.; Dormire – 
Cristália Produtos Químicos Farmacêuticos Ltda. – 
Itapira-SP, Brazil), and two minutes after anesthetic 
induction, 10% guaiphenesin (100 mg/kg i.v.) was 
administered. Once the animal was recumbent and 
orotracheal intubation was performed, horses were 
positioned in dorsal recumbency on foam padding 
and connected to a large animal closed circular anes-
thetic circuit (Línea C – Intermed Produtos Médicos 
Hospitalares Ltda. - São Paulo-SP, Brazil). The lungs 
were mechanically ventilated with tidal volume of 10 
ml/kg, positive end-expiratory pressure of 5 cmH20 
and  respiratory rate (RR) (WinTracer version 3.3 
beta, Intermed Produtos Médicos Hospitalares Ltda. 
- São Paulo-SP, Brazil) adjusted to maintain arterial 
partial pressure of carbon dioxide (PaCO2) between 
35-50 mmHg (ABL 555 – Radiometer – Copenhagen, 
Denmark). Anesthesia was maintained at an end-tidal 
isoflurane (Isoforine – Cristália Produtos Químicos 
Farmacêuticos Ltda. – Itapira-SP, Brazil) of 1.5-1.7% 
vaporized in 0.8 inspired oxygen fraction (FiO2) (Po-
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etIQ – Criticare Systems Inc. – Waukesha-WI, USA). 
Self-adhesive patches were applied to the skin for re-
cording ECG and heart rate (HR) (Viridia CMS 66S 
– Hewlett Packard – Andover/MA - USA). The facial 
artery was catheterized with a 22 gauge catheter (Ni-
pro Medical Ltda. – Sorocaba/SP, Brazil), connected 
to a calibrated pressure transducer and systolic, dia-
stolic and mean arterial blood pressures (MABP) 
were recorded (Viridia CMS 66S – Hewlett Packard 
– Andover/MA – USA). Ephedrine infusion (0.02 
mg/kg/min; Efedrin – Cristália Produtos Químicos 
Farmacêuticos Ltda. – Itapira-SP, Brazil) was initiated 
after 20 minutes of isoflurane anesthesia for cardio-
vascular support in horses with MABP < 60 mm Hg. 
Infusion was administered to maintain mean MABP 
at 65 – 70 mm Hg and time of infusion was registered.
The HT was measured by the microhematocrit cen-
trifugation method by using venous blood samples 
collected from the jugular vein. HT, HR and RR were 
measured immediately before preanesthetic medica-
tion (baseline), 10 minutes after preanesthetic medi-
cation (10BL), 12 minutes after preanesthetic medi-
cation (2 minutes after induction; 12BL), 17 minutes 
after preanesthetic medication (5 minutes after guai-
phenesin; 17BL), 40 minutes after preanesthetic med-
ication (after the initial 20 minutes of isoflurane anes-
thesia; 40BL), 60 minutes after preanesthetic medica-
tion (after the initial 40 minutes of isoflurane anes-
thesia; 60BL), 10 minutes after standing (ST) and 24 
hours after preanesthetic medication (24hBL). MABP 
and end tidal isoflurane were measured at 40BL and 
60BL. Blood gas values were measured at baseline, 
40BL and ST, and rectal temperature was measured at 
baseline, 40BL, 60BL and ST.
Data were statistically analyzed using analysis of 
variance (ANOVA) for repeated measurements (In-
Stat 3.01 – GraphPad – San Diego-CA, USA) followed 
by Tukey test for comparison of different time points 
of the same group. t-Student test was used to evalu-
ate possible differences between groups and statistical 
significance was considered as p<0.05.
Results
In both groups HT decreased significantly at 40BL, 
60BL and ST compared to baseline. This effect had an 
earlier onset in XYL group (17BL, p<0.05) compared 
to XYL+ACP group (40BL; p<0.01). The greatest de-
crease in HT was observed at 60BL in both groups, 
consisting of a 19% fall in XYL group (29 ± 6.8%, 
p<0.001) and a 17% fall in XYL+ACP group (30 ± 
4.5%, p<0.001). At 24hBL HT was similar than base-
line values. There were no significant differences in 
HT between groups (Table 1). 
In both groups horses had MABP lower than 60 mm 
Hg at 40BL. XYL+ACP group had values of MABP 
significantly lower than XYL group at 40BL (p<0.05). 
Both groups had significant increase of MABP at 
60BL (p<0.05), which were higher than 60 mm Hg 
(Table 1).
Rectal temperature was significant lower at 40BL, 
60BL and ST compared to baseline (p<0.05) in both 
groups. End tidal isoflurane was significantly lower 
in XYL+ACP group compared to XYL group at 60BL 
(p<0.05) (Table 1).
HR, RR and arterial blood gas values did not change 
significantly along the study and were within the 
range of normal values in both groups (Table 1). 
XYL+ACP group received a total volume of ephed-
rine (582 ± 91 mL) significantly higher than XYL 
group (278 ± 87 mL) (p<0.05). No significant differ-
ence in time of infusion was observed among groups 
(34 ± 6 minutes in XYL group; 35 ± 5 minutes in 
XYL+ACP group).
Discussion
The most marked decrease in HT was 17% and 19%, 
occurring after 1 hour of premedication, in XYL and 
XYL+ACP groups, respectively. 
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In XYL group HT decrease (19%) was similar to the 
observed by Robertson10 (15%) using XYL (1.1 mg/
kg), KET (2.2 mg/kg) and halothane. In both studies, 
this XYL effect in HT was predominant over the other 
anesthetic drugs administered and started after about 
20 minutes of XYL administration with duration lon-
ger than 3 hours. Unlike the present study Wagner et 
al.11 did not observe any variation of HT in horses re-
ceiving bolus of XYL (0.15 mg/kg) and KET (0.3 mg/
kg) followed by infusions of both drugs (0.02 mg/kg/
min and 0.06 mg/kg/min, respectively). This context 
suggests that a minimum dose of i.v. XYL is probably 
necessary to produce relaxation of splenic capsule and 
vessels of horses and HT decrease. 
In the XYL+ACP group despite the lower dose 
of XYL compared to XYL group, it was observed a 
Parameter Group Baseline 10BL 12BL 17BL 40BL 60BL ST 24hBL
Hematocrit XYL 36 ± 5.9 36 ± 7.4 35 ± 6.2 32 ± 5.8* 30 ± 6.0* 29 ± 6.8* 32 ± 7.9* 34 ± 4.5
(%) XYL+ACP 36 ± 3.5 36 ± 3.0 37 ± 5.4 34 ± 4.3 31 ± 4.2* 30 ± 4.5* 31 ± 3.8* 36 ± 4.3
RR XYL 17 ± 3 13 ± 2 13 ± 2 13 ± 2 10 ± 1 10 ± 1 17 ± 3 17 ± 2
(breaths/min) XYL+ACP 16 ± 2 13 ± 2 12 ± 2 10 ± 2 9 ± 1 9 ± 1 11 ± 2 16 ± 3
HR XYL 36 ± 6 32 ± 9 38 ± 8 37 ± 6 39 ± 7 40 ± 7 43 ± 6 38 ± 7
(beats/min) XYL+ACP 35 ± 3 32 ± 7 34 ± 9 37 ± 8 42 ± 9 41 ± 6 38 ± 8 35 ± 7
MABP XYL - - - - 56 ± 8 70 ± 8§ - -
(mm Hg) XYL +ACP - - - - 43 ± 5† 62 ± 2§ - -
Rectal temp. XYL 37.7 ± 0.4 - - - 36.0 ± 0.9* 35.7 ± 0.9* 36.2 ± 0.7* 37.8 ± 0.4
(oC) XYL +ACP 37.4 ± 0.4 - - - 36.4 ± 0.8* 35.9 ± 0.6* 36.4 ± 0.6* 37.8 ± 0.5
End tidal XYL - - - - 1.29 ± 0.3 1.20 ± 0.2 - -
isoflurane (%) XYL +ACP - - - - 1.26 ± 0.3 1.05 ± 0.2§ - -










PaCO2 XYL 41 ± 6 - - - 46 ± 4 - 41 ± 5 -
(mm Hg) XYL+ACP 40 ± 2 - - - 45 ± 5 - 43 ± 3 -
PaO2/FiO2 XYL 462 ± 44 - - - 418 ± 93 - 438 ± 73 -
XYL+ACP 469 ± 35 - - - 403 ± 95 - 438 ± 39 -
SaO2 XYL 97 ± 1.9 - - - 99 ± 1.5 - 96 ± 1.9 -
(%) XYL+ACP 97 ± 1.9 - - - 100 ± 0.7 - 95 ± 5.4 -
Plasmatic 
bicarbonate XYL 25 ± 2.2 - - - 25 ± 2.8 - 27 ± 2.7 -
(mEq/L) XYL+ACP 24 ± 1.6 - - - 25 ± 2.1 - 26 ± 2.5 -
Table 1 – Hematocrit, respiratory rate (RR), heart rate (HR), mean arterial blood pressure (MABP), rectal temperature, 
end tidal isoflurane and blood gas values of horses from XYL group (xylazine 0.8 mg/kg, i.v.) and XYL+ACP 
group (xylazine 0.5 mg/kg plus acepromazine 0.05 mg/kg, i.v.). Data are presented as mean ± standard deviation
Baseline - immediately before preanesthetic medication, 10BL - 10 minutes after preanesthetic medication and immediately prior to 
induction, 12BL – 12 minutes after preanesthetic medication and 2 minutes after induction, 17BL – 17 minutes after preanesthetic 
medication and 5 minutes after guaiphenesin, 40BL – 40 minutes after baseline and 20 minutes of isoflurane anesthesia, 60BL – 60 
minutes after baseline and 40 minutes of isoflurane anesthesia, ST - 10 minutes after standing, 24BL - 24 hours after preanesthetic 
medication. * within a group, value is significantly different than the Baseline value for this variable (p<0.05). § within a group, value is 
significantly different than the 40BL value for this variable (p<0.05). † Within this time point, value is significantly different than other 
treatment (p<0.05). São Paulo/SP, 2008
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similar decrease in HT which was attributed to the 
addition of ACP. According to Wood et al.3 HT de-
crease is considered to be an important effect after 
30 minutes of ACP administration and i.v. doses as 
low as 0.0001 mg/kg are capable to decrease HT in 
10% for up to 2 hours after administration. Reduc-
ing the dose to 0.00005 mg/kg i.v. totally eliminates 
this effect and increasing the dose to 0.006 mg/kg i.v 
increases this effect to 18%. Administration of higher 
doses prolonged this effect but did not produce sig-
nificant increases in the magnitude of this effect5,12. 
Indeed, the 17% decrease on HT in XYL+ACP group 
was similar to the 20% decrease reported by Wood et 
al.3 after administration of 0.01 mg/kg i.v. and by Par-
ry and Anderson5 after administration of a dose ten 
times higher (0.10 mg/kg i.v.). Similarly, Luna, Taylor 
and Massone13 reported a significant decrease on HT 
(17%) after 20 minutes of ACP administration (0.03 
mg/kg i.v.) that lasted 4 hours of anesthesia with ket-
amine, midazolam and halothane. According to Lang, 
Eglen and Henry14, this limited amount by which HT 
decreases is probably explained by the dependence 
on the splenic storage capacity which, therefore, may 
plateau HT levels with increasing ACP doses. There-
fore, it is suggested that HT levels decreased similarly 
in both groups, because both anesthetic protocols 
achieved splenic storage capacity, regardless of the 
preanesthetic medication administered.
After about 3 hours of premedication, when horses 
had already recovered the standing position, HT val-
ues had not returned to baseline in both groups, which 
would be expected on horses that received ACP based 
on Parry and Anderson5 studies, that reported signifi-
cant reductions in HT values in horses for 12 hours 
after ACP administration of 0.05 mg/kg i.v. and for 
21 hours after 0.15 mg/kg i.v. In horses administered 
only XYL as preanesthetic medication, this effect was 
not expected since this drug has a shorter action, but 
similar results were obtained by Robertson10, who re-
ported HT decreasing for more than 3 hours. 
The sympathomimetic effect of KET and EPH is 
capable to produce splenic contraction and increase 
HT15,16. The alpha-adrenolytic activity of XYL and 
ACP can promote splenic relaxation with conse-
quent erythrocyte storage in the spleen5 and this ef-
fect would have overwhelmed the splenic contrac-
tion caused by the adrenergic drugs. The association 
of midazolam to KET may also have contributed for 
the maintenance of HT levels after anesthetic induc-
tion which was also observed by Mello, Castro Jr. and 
Silva Filho17. Midazolam is capable to prevent the in-
crease in catecholamine levels caused by ketamine13 
and probably avoided the adrenergic effects of this 
dissociative anesthetic in the spleen capsule and ves-
sels and the increase in HT. In addition, guaiphenesin 
may have contributed for HT decrease due to a hemo-
dilution effect.
The maintenance of HT after EPH infusion was 
also described in horses by Hellyer et al.9 but with the 
dose of 0.06 mg/kg. Dobutamine, an inotrope admin-
istered in anesthetized horses for cardiovascular sup-
port, produces a marked HT increase, which would 
also be expected after EPH administration, since 
these drugs act by an alpha-adrenergic activity that 
may cause splenic contraction9. However, considering 
the results observed in both studies there is probably 
a dose-dependent contraction of the splenic vascular 
bed and capsule after EPH injection in horses similar 
to observed in dogs by Davies and Withrington16 and 
the dose administered in horses to treat hypotension 
may be insufficient to cause a significant splenic con-
traction. 
Anesthetic maintenance with isoflurane may also 
have contributed for HT increase by increasing en-
dogenous catecholamine’s release reported in horses 
anesthetized with inhalant agents7. However, this ef-
fect is more prominent in halothane anesthetized 
horses. In addition, the magnitude of this effect or the 
short duration of the inhalation anesthesia may not 
be capable to significant change HT in horses anes-
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